Table 2.
Virus | HSV | HPV | EBV | EBV-HPV co-infection |
EBV/HPV 16 | EBV/HPV18 | EBV/HPV16&18 | EBV/HPV31 |
---|---|---|---|---|---|---|---|---|
Frequency | 0/101 | 91/101 (90%) | 13/101 (12.8%) | 13/101 (12.8%) | 3/13 (23%) | 1/13 (7.60%) | 8/13 (61.50%) | 1/13 (7.60%) |
LSIL | 0 | 26/91 (28.6%) | 2/13 (15%) | 2/2 (100%) | 0 | 1/2 (50 %) | 1/2 (50 %) | 0 |
HSIL | 0 | 39/91 (42.8%) | 8/13 (61%) | 8/8 (100%) | 2/8 (25%) | 0 | 6/8 (75%) | 0 |
SCC | 0 | 23/91 (25.2%) | 3/13 (23%) | 3/3 (100%) | 1/3 (33.30%) | 0 | 1/3 (33.30%) | 1/3 (33.30%) |
ADC | 0 | 3/91 (3.2%) | 0 | 0 | 0 | 0 | 0 | 0 |